i360 Medical signs diagnostic deal with US and Asian firms
Irish healthcare solutions and medical device innovation company, i360 Medical has signed a deal with the US-based Feinstein Institute for Medical Research and Singapore’s Diagnostics Development Hub.
The deal has been agreed to target the development of medical device and diagnostic technologies with an initial focus on surgical procedures, intra-operative diagnostics and diabetic management.
The chief executive of i360 Medical, Derek Young, said the deal will help benefit patients.
“Both of our partners are recognised as global leaders in their areas are we are excited to combine our networks with the goal of developing and commercialising breakthrough technologies for the healthcare of tomorrow,” Mr Young said.
The firm’s chief executive also believes that the deal will help add to Ireland’s growing medical start-up scene.
“This will benefit Ireland by bringing more ‘medtech’ startups here and by leveraging the combined international network of the three bodies to launch these startups commercially into the international healthcare markets,” Mr Young added.
i360 Medical taps into Ireland’s growing medical device expertise, has joined with some of the world leaders in healthcare innovation to generate and commercialise new world-class healthcare technology. The board of i360medical includes industry leaders: Cleveland Clinic’s Chris Coburn, Synecor’s Richard Stack and Bill Starling, RCSI’s Oscar Traynor and Kernel Capital’s Peter Sandys.